We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+10.63%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$15.2B
AUM Growth
+$4.78B
Cap. Flow
+$3.57B
Cap. Flow %
23.39%
Top 10 Hldgs %
44.86%
Holding
2,187
New
553
Increased
436
Reduced
404
Closed
789

Top Sells

Rank Stock Value
1
VMW
VMware, Inc
VMW
+$95.7M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$89.4M
3
XOM icon
ExxonMobil
XOM
+$84.7M
4
SO icon
Southern Company
SO
+$79.2M
5
EMR icon
Emerson Electric
EMR
+$61.3M

Sector Composition

Rank Sector Weight
1 Technology 9.26%
2 Industrials 7.84%
3 Utilities 7.6%
4 Healthcare 5.4%
5 Real Estate 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLYA
351
DELISTED
Playa Hotels & Resorts
PLYA
$4.85M 0.03%
560,792
+293,670
+110% +$2.21M
HGV icon
352
Hilton Grand Vacations
HGV
$3.51B
$4.81M 0.03%
119,695
+90,137
+305% +$3.38M
DDS icon
353
Dillards
DDS
$9.71B
$4.78M 0.03%
11,846
-9,264
-44% -$3.14M
TEL icon
354
TE Connectivity
TEL
$58.9B
$4.78M 0.03%
34,021
-77,696
-70% -$9.99M
MO icon
355
Altria Group
MO
$110B
$4.74M 0.03%
117,520
+101,352
+627% +$4.19M
EA
356
DELISTED
Electronic Arts
EA
$4.74M 0.03%
34,626
+13,661
+65% +$1.81M
TARS icon
357
Tarsus Pharmaceuticals
TARS
$3.19B
$4.72M 0.03%
232,900
-165,741
-42% -$2.77M
CCK icon
358
Crown Holdings
CCK
$13B
$4.66M 0.03%
50,588
+37,748
+294% +$3.2M
NBR icon
359
Nabors Industries
NBR
$1.37B
$4.65M 0.03%
+56,978
New +$5.52M
MRVL icon
360
Marvell Technology
MRVL
$213B
$4.63M 0.03%
+76,713
New +$4.14M
AOS icon
361
A.O. Smith
AOS
$8.57B
$4.61M 0.03%
55,900
-13,209
-19% -$974K
BWXT icon
362
BWX Technologies
BWXT
$14.4B
$4.59M 0.03%
+59,878
New +$4.6M
JWN
363
DELISTED
Nordstrom
JWN
$4.59M 0.03%
248,731
+167,410
+206% +$2.57M
CRNX icon
364
Crinetics Pharmaceuticals
CRNX
$8.99B
$4.54M 0.03%
127,682
+98,743
+341% +$3.03M
ELV icon
365
Elevance Health
ELV
$86.9B
$4.54M 0.03%
9,631
-9,221
-49% -$4.26M
BLDR icon
366
Builders FirstSource
BLDR
$7.55B
$4.53M 0.03%
27,152
+20,685
+320% +$2.75M
SIG icon
367
Signet Jewelers
SIG
$3.16B
$4.53M 0.03%
+42,208
New +$3.46M
HUN icon
368
Huntsman Corp
HUN
$1.75B
$4.51M 0.03%
179,632
+103,859
+137% +$2.53M
ALV icon
369
Autoliv
ALV
$9.18B
$4.48M 0.03%
+40,669
New +$4.05M
SM icon
370
SM Energy
SM
$8.85B
$4.47M 0.03%
115,473
-60,748
-34% -$2.34M
EXEL icon
371
Exelixis
EXEL
$13.4B
$4.46M 0.03%
186,051
-356,160
-66% -$7.74M
ZBRA icon
372
Zebra Technologies
ZBRA
$17.4B
$4.46M 0.03%
+16,324
New +$3.73M
AGNC icon
373
CALL
AGNC Investment
AGNC
$12.9B
$4.42M 0.03%
+450,100
New +$3.96M
URBN icon
374
Urban Outfitters
URBN
$6.36B
$4.37M 0.03%
122,296
+74,006
+153% +$2.58M
STWD icon
375
Starwood Property Trust
STWD
$6.06B
$4.35M 0.03%
207,106
+153,217
+284% +$3.01M

Similar funds

Michael Gelband's Q4 2023 Portfolio in Review

As of Q4 2023, Michael Gelband held 2,187 positions worth $15.2B, up 46% from $10.5B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Michael Gelband deployed $3.57B of net new capital in Q4 2023, opening 553 new positions and adding to 436 existing holdings. Its largest new stake was Fidelity National Information Services: 6,650,397 shares worth $399M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 10% a quarter earlier, followed by Industrials and Utilities.

On the sell side, the largest reduction was Merck, an estimated $48.2M trimmed.

  • Michael Gelband's largest Q4 2023 buy was Fidelity National Information Services: 6,650,397 shares worth $399M.
  • Michael Gelband added most to Global Payments in Q4 2023, an estimated $250M increase.
  • Michael Gelband's biggest Q4 2023 reduction was Merck, cutting an estimated $48.2M.
  • Michael Gelband fully exited VMware, Inc in Q4 2023, selling an estimated $95.7M.
  • Michael Gelband's ten largest holdings make up 45% of its $15.2B portfolio in Q4 2023.
  • Michael Gelband opened 553 new positions and closed 789 in Q4 2023.
  • Michael Gelband's portfolio value rose 46% quarter-over-quarter to $15.2B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.